In new research, Wolfgang Kerber argues that the European Union's decision to require a third option in Meta's "consent or pay" model focuses too heavily on user consent and ignores the broader goal in the Digital Markets Act of reducing gatekeeper advantages and increasing competition.

COMMENTARY

The “Major Questions Doctrine” Precludes a Merger Efficiency Defense

For decades antitrust agencies, courts, and scholars have debated whether Section 7 of the Clayton Act permits an efficiency defense, in which merging firms can argue that enhanced efficiencies from the merger show that it does not reduce competition. However, the Supreme Court’s recent establishment of the “major questions doctrine,” which enforces or re-enforces a textualist reading of regulatory statues, undermines proponents of the efficiency defense, because the Clayton Act does not clearly and explicitly contain an efficiency defense. The “major questions doctrine” essentially acts as textualism on steroids,” writes Robert H. Lande.

RESEARCH

SVB Shows Giving Growing Banks More Time To Meet Standards Comes With Risks

As banks grow, tiered regulation places them in stricter categories to address their greater risks. In new research, Pedro M. Batista finds that transition periods between tiers might delay when some higher standards become mandatory, potentially leaving growing banks exposed while known risks remain unresolved, as happened with Silicon Valley Bank. Federal Reserve reforms should address this gap between growing risks and delayed safeguards.
spot_img
spot_img

A New Capitalisn’t Episode

Subscribe to promarket newsletter

Join our email newsletter

LATEST

Finding a New Direction for the Common Good

Matt Lucky reviews Mariana Mazzucato’s new book The Common Good Economy: A new compass, now out at Basic Venture Group.

Top Scientific Research Is Globalizing, But Economics Is Becoming More Concentrated

Prizewinning research in most science-related academic fields has become less concentrated among institutions. However, as Richard B. Freeman, Danxia Xie, Hanzhe Zhang, and Hanzhang Zhou discuss in new research, prizewinners in economics continue to come from a narrow set of American institutions.  

Bank Concentration Undermined the Fed’s Monetary Policy During the Last Tightening Cycle

In new analysis, Madhav Parikh examines how competition among banks in the United States shapes the way monetary policy reaches depositors. Tracking U.S. banks from late 2021 through mid-2026, he finds that banks in more concentrated local markets repriced their deposit interest rates less than banks in competitive markets, both as the Fed raised rates and as it cut them.

Private Enforcement of the DMA Brings Efficiencies yet Potential Disharmony

The Digital Markets Act establishes central rules and enforcement for digital platforms across the European Union, but allows decentralized private enforcement on the national level. In new research, Lena Hornkohl and Barbara Justen reflect on how two recent German court cases show how national litigation can make the DMA more effective, but also highlight the need for mechanisms that aid in consistent interpretation.

The Affordability Crisis, Antitrust, and Consumer Anxiety

Consumers are anxious about the economy, and it’s due not only to inflation but to market power that raises prices and reduces quality, variety, and innovation. Policymakers’ prescriptions for resolving the cost-of-living crisis have mostly ignored the role of antitrust policy, but waning competition is at the heart of these problems, writes Diana L. Moss.

READING LISTS

Americans spend significantly more on health care than any other country. Why? Answers to this question range from hospital monopolies to perverse incentives to opaque pricing to medical licensing to pharmaceutical firms abusing IP practices to “creeping consolidation.” Why is the US health care system so broken? And what can antirust do about it? Catch-up on our coverage of antitrust and the US health care system.

Congress Has More Work to Do Before PBM Reform Reaches Consumers      

Jeremy Pilaar and Albert (Haotian) Wang present the weaknesses in current legislative reforms targeting pharmacy benefit managers. They suggest that lawmakers focus on reining in PBM income, limiting fees that PBMs can charge, and empowering state legislative efforts.  

The Prescription for Better Health Insurance? Competition.

Anticompetitive behavior, such as consolidation, in the health-insurance industry has allowed a small group of insurers to dominate the market. One of the main drivers of this behavior is “adverse selection,” where individuals know more about how sick they are than insurance companies do. To mitigate the risk of paying out more claims than they can cover, insurers often raise their premiums. Kellogg’s Amanda Starc and her colleague argue that, to create a truly healthy health-insurance marketplace, regulators and policymakers need a framework for rethinking the complex interactions between adverse selection and regulatory guardrails.

Antitrust as a Cure for the Private Equity Disease

The United States healthcare system has experienced an expansion of private equity ownership. In new research, Theodosia Stavroulaki argues that private equity acquisitions risk harming healthcare by increasing prices, reducing quality of care, limiting access to care, and hurting the labor force.

Pharma’s AI Boom Has Bet on the Wrong Bottleneck

Investors have poured billions into using artificial intelligence to discover new drugs, and 2026 is the first real test of whether AI-designed medicines actually helps patients. The boom has genuinely transformed the search for molecules — but that was never the costly, failure-prone part of making a medicine, and there AI has so far had little to add. Capital, and the public subsidies have not yet priced the difference, writes Michael A. Santoro.

George J. Stigler, one of the most influential economists of the 20th century, won the Nobel Prize in Economic Sciences in 1982 “for his seminal studies of industrial structures, functioning of markets, and causes and effects of public regulation.” His research upended the idea that government regulation was effective at correcting private-market failures. Stigler introduced the idea of regulatory capture, in which regulators could be dominated by special interests. These regulators would work for the benefit of large, monied organizations rather than the public good. Catch up on ProMarket's coverage of his legacy.

Term-Limited Leaders Are More likely To Respond to Financial Crises by Helping Banks—and Themselves—Over the Public

Financial crises routinely trigger sweeping overhauls of financial regulation, but whose interests do these reforms serve? In new research, Orkun Saka, Yuemei Ji, and Clement Minaudier find that political leaders facing term limits are much more likely to respond to financial crises by introducing reforms that benefit banks over the public or long-term financial stability. This phenomenon occurs more frequently in countries where the revolving door between politics and finance is common.

Why Personalized Pricing Won’t Work the Way Critics Fear

Firms can now charge each shopper a different price, and regulators worry that the gains will flow from consumers to companies. But personalized pricing has two built-in limits: shoppers learn to hide how much they want things, and cheap purchases can be resold, writes Nursultan Mukhtaruly.

Domestic Supply Chains in the US Are Fracturing Along Partisan Lines

In new research, Nandini Gupta and Swarnodeep Homroy show that firms in the United States are choosing politically-aligned suppliers to insure their supply chains against disruption. Aligned relationships are markedly more resilient when shocks hit, but the insurance is paid for in higher input costs and less innovation.

Product Liability Beats Antitrust in the Fight for Human Attention

In new research, Elettra Bietti compares the efficacy of the two legal avenues that have arisen to restrain social media’s ability to monopolize people’s time and attention: antitrust policy and product liability for consumer harm. Looking at the results of two recent Meta cases, she finds that product liability has proven the most capable in introducing the frictions needed to reduce social media’s addictive design.

Brazil’s Bill To Regulate Digital Market Illustrates How Markets Are Made, Not Found

The Chicago School believed that markets operate best when they are left to organize themselves, and that state regulation only disrupts this process to the detriment of social welfare. Brazil’s Competition Act for Digital Markets, now under legislative debate, reveals the myopia of the Chicago School’s organizing principle and instead supports the heterodox institutionalist position that state activity, whether through activity or abstention, is always at the heart of market formation, writes Diogo Rosenthal Coutinho. In the Chicago School account...

The American AI Exports Program Risks Stifling Smaller Competitors

The United States government launched the American AI Exports Program to help American firms win contracts from international customers. In a bid to enhance international competitiveness, the program risks stifling domestic competition, writes Javaid Sofi.

Antitrust Policy Can Be Captured Without Lobbying

In new research, Nicholas Short, Sophie Hill, and Jacob Brown examine "ideological capture": regulatory capture that works not through lobbying but through experts defining what goals and values regulators may consider. Surveying the public alongside antitrust lawyers, they find the consumer welfare standard marginalizes important public concerns, like the risk of increased layoffs or more lobbying power.

COLUMNS

spot_imgspot_img